Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E7 TCR T Cell Induction Immunotherapy for HPV+ Oropharyngeal Cancer
NCT04015336Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Jul 2020
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
A Phase 2 trial of KITE-439 in human papillomavirus-positive oropharyngeal squamous cell carcinoma, sponsored by National Cancer Institute. Started Jul 2020; status: terminated.
02
Drugs
KITE-439
03
Conditions
human papillomavirus-positive oropharyngeal squamous cell carcinoma
Beyond the preview
Go deeper on NCT04015336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04015336.